These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Alemtuzumab (Campath-1H) for treatment of refractory polymyositis. Thompson B; Corris P; Miller JA; Cooper RG; Halsey JP; Isaacs JD J Rheumatol; 2008 Oct; 35(10):2080-2. PubMed ID: 18843768 [No Abstract] [Full Text] [Related]
11. [Case report and discussion of a patient with polymyositis, fibrosing alveolitis and scleroderma-like involvement of the right hand]. Wunderlin B; Knüsel O; Kummer H Z Rheumatol; 1996; 55(3):188-97. PubMed ID: 8768149 [TBL] [Abstract][Full Text] [Related]
12. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Smolen JS; Beaulieu A; Rubbert-Roth A; Ramos-Remus C; Rovensky J; Alecock E; Woodworth T; Alten R; Lancet; 2008 Mar; 371(9617):987-97. PubMed ID: 18358926 [TBL] [Abstract][Full Text] [Related]
14. A study to evaluate the safety, tolerability, and efficacy of brodalumab in subjects with rheumatoid arthritis and an inadequate response to methotrexate. Pavelka K; Chon Y; Newmark R; Lin SL; Baumgartner S; Erondu N J Rheumatol; 2015 Jun; 42(6):912-9. PubMed ID: 25877498 [TBL] [Abstract][Full Text] [Related]
15. A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years. Nakahara H; Mima T; Yoshio-Hoshino N; Matsushita M; Hashimoto J; Nishimoto N Mod Rheumatol; 2009; 19(1):69-72. PubMed ID: 18762861 [TBL] [Abstract][Full Text] [Related]
17. Reduction of biological agent dose in rheumatic diseases: descriptive analysis of 153 patients in clinical practice conditions. Inciarte-Mundo J; Hernández MV; Rosario V; Ruiz-Esquide V; Cabrera-Villalba S; Ramírez J; Cañete JD; Sanmartí R Reumatol Clin; 2014; 10(1):10-6. PubMed ID: 23876791 [TBL] [Abstract][Full Text] [Related]
18. Infliximab in a case of early adult-onset Still's disease. Olivieri I; de Stefano G; Padula A; La Gala A; de Stefano C Clin Rheumatol; 2003 Oct; 22(4-5):369-70. PubMed ID: 14579170 [No Abstract] [Full Text] [Related]
19. [Patient with eosinophilic polymyositis]. de Kruijf EJ; Rothbarth J; van Duinen SG; de Meijer PH; Meinders AE Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2019-23. PubMed ID: 11072522 [TBL] [Abstract][Full Text] [Related]
20. Summaries for patients. Adalimumab for the treatment of hidradenitis suppurativa. Ann Intern Med; 2012 Dec; 157(12):I-50. PubMed ID: 23247950 [No Abstract] [Full Text] [Related] [Next] [New Search]